Continuous Subcutaneous Infusion of Pramlintide and Insulin

NCT00291772 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Pramlintide

Sponsor

Baylor College of Medicine